Published in AIDS Weekly, March 24th, 2003
This European SLS program is part of the larger Fuzeon Early Access Program announced last year. The initiation of SLS programs will ensure that Fuzeon is made available as soon as possible for the growing number of Europeans living with HIV/AIDS who have limited treatment options. The SLS program price announced will be indicative of eventual global commercial prices;...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.